Product Images Pregabalin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 15 images provide visual information about the product associated with Pregabalin NDC 70518-3647 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

MM2 - Pregabalin 150mg 70518 3647 01

MM2 - Pregabalin 150mg 70518 3647 01

The text describes a medication called Pregabalin, which is available in 150mg capsules with a quantity of 60 capsules. It is prescription only and has a specific NDC number and LOT number for tracking purposes. The manufacturer is Ascend Labs, LLC and it should be kept out of the reach of children. The directions for use can be found in the package insert and it should be stored at 20-25°C (88-77°F) with excursions allowed up to 15-30°C (59-86°F). It has been repackaged by RemedyRepack Inc. in Indiana, PA.*

Remedy_Label - Remedy Label

Remedy_Label - Remedy Label

Pregabalin is a medication in capsule form with a concentration of 150mg. The pack contains 90 capsules and requires a prescription. A National Drug Code (NDC) number for identification is provided. The lot number and expiration date are not available. The medication was manufactured by Ascend Labs and repackaged by RemedyRepack. The package insert provides specific directions for use, and it is recommended to store the medicine at 20-25°C (88-77°F) with excursions permitted to 15-30°C (59-86°F). The label includes a caution to keep the medication away from children.*

pregabalin-equation - pregabalin equation

pregabalin-equation - pregabalin equation

This appears to be a medical formula for estimating creatinine clearance (CLCr) in female patients based on age (in years), weight (in kilograms), and serum creatinine level (in mg/dL). However, without additional context or units of measurement, it is difficult to provide a more detailed description.*

pregabalin-Figure-6 - pregabalin figure 6

pregabalin-Figure-6 - pregabalin figure 6

This appears to be a table showing results of two studies (E1 and E3) on a product, with different dosages and a placebo group. Based on the limited text, it is not clear what the product is or what the studies were testing for. However, the table shows statistical significance of some doses compared to placebo.*

pregabalin-Figure-7 - pregabalin figure 7

pregabalin-Figure-7 - pregabalin figure 7

Study DPN 1 - pregabalin image 1

Study DPN 1 - pregabalin image 1

Study SCI 1 - pregabalin image 10

Study SCI 1 - pregabalin image 10

Pain Intensity-study SCI 2 - pregabalin image 11

Pain Intensity-study SCI 2 - pregabalin image 11

Study DPN 2 - pregabalin image 2

Study DPN 2 - pregabalin image 2

Study PHN 1 - pregabalin image 3

Study PHN 1 - pregabalin image 3

Study PHN 2 - pregabalin image 4

Study PHN 2 - pregabalin image 4

Percentage improvement in pain from baseline. The rest of the text is not available because it contains random characters and does not make sense.*

Study PHN 3 - pregabalin image 5

Study PHN 3 - pregabalin image 5

Fibromyalgia Study F1 - pregabalin image 8

Fibromyalgia Study F1 - pregabalin image 8

This is a chart showing the percent of patients who improved in pain from baseline after taking different doses of Pregabalin, with 100% improvement seen in patients who took a daily dose of 600mg.*

Fibromyalgia Study F2 - pregabalin image 9

Fibromyalgia Study F2 - pregabalin image 9

Pregabalin structure - pregabalin srtuc 1

Pregabalin structure - pregabalin srtuc 1

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.